Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 121.59 -1.05 (-0.86%) Market Cap: 7.35 Bil Enterprise Value: 10.93 Bil PE Ratio: 17.13 PB Ratio: 1.76 GF Score: 85/100

Jazz Pharmaceuticals PLC at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript

Sep 27, 2021 / 08:40PM GMT
Release Date Price: $133.83 (-1.12%)
Brandon Richard Folkes;Renee D. Gala
Cantor Fitzgerald & Co., Research Division - Analyst;Jazz Pharmaceuticals plc - Executive

Good afternoon, everyone, and thank you very much for joining us at the Cantor Fitzgerald 2021 Virtual Healthcare Conference. My name is Brandon Folkes, and I'm one of the biopharma analyst here at Cantor. Next up, we have a fireside chat with Jazz Pharmaceuticals. And joining us from Jazz is Renee Gala, Executive Vice President and Chief Financial Officer; as well as Dan Swisher, President; and Dr. Rob Iannone, Executive Vice President, Research and Development and Chief Medical Officer. Thank you for all joining us today.

Just a quick word to the audience. Should we run short of Q&A time, if I don't get to everyone's questions, please feel free to either add them into the chat feature or e-mail them directly to me. I will get them across to Renee and the team and get them answered. So Renee and team, thank you very much again for joining us.

And Renee I'm going to pass it over to you for some opening remarks. Thank you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot